News und Analysen

Advances in artificial intelligence (AI) and the excitement around their potential drove the stock prices of some of the biggest companies in the world higher in 2024. But not every AI innovator was

When it comes to dividend investing, there are two basic paths you can take. You could seek out businesses that are raising their payouts at a rapid pace, but these stocks tend to offer low yields

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company.

*Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on

Viking Therapeutics (NASDAQ: VKTX) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's share price eroded by 24% in December, primarily on the back of a

The best dividend stocks can provide you with bountiful streams of passive income. With their lower risk and volatility profiles, these stalwart stocks should also help you protect your wealth while

With shares of the popular dividend exchange-traded fund (ETF) Schwab US Dividend Equity ETF (NYSEMKT: SCHD), investors are wondering whether it is time to dump the ETF or double up. In today's

Over the last couple of years, technology stocks have captivated the investment world thanks in large part to breakthroughs in artificial intelligence (AI).

Within the AI realm, semiconductor stocks

Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in

No one knows for sure what the new year will hold for the market. However, some stocks' chances for success look particularly good.

We asked three Motley Fool contributors to pick healthcare stocks

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn't

If you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Having to spend more just to maintain their current standard of living is a

Shares of UnitedHealth Group (NYSE: UNH) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on

Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth.

*Stock prices used were the afternoon prices of Dec. 31, 2024. The video was published on Jan

It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results, its stock skyrocketed in February. And although it's

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. However, the drugmaker has since seen its shares decline

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and recent updates impacting the company. To learn more, check out the short video, consider subscribing, and click the special offer

The stock market enjoyed a strong year in 2024 as the S&P 500 hit new records. The challenge for investors looking to get into the market amid such a strong bull run, however, is that valuations

The past year has been a solid one for semiconductor companies, as evident from the 21% gains clocked by the PHLX Semiconductor Sector index during this period. But not all semiconductor stocks have

Artificial intelligence (AI) has come a long way in recent years. Businesses are starting to see tangible savings from implementing this technology in their operations, which is triggering massive

Buying growth stocks into a potential stock market sell-off may seem counterintuitive. After all, who wants to load up on stocks only to see them fall? But long-term investing isn't about timing the

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb (NYSE: BMY) and Merck & Co. (NYSE: MRK) stand out for their

The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents protecting their proprietary drugs expire. Pfizer (NYSE: PFE), a longtime

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and questions investors should consider if planning to hold throughout 2025. To learn more, check out the short video, consider

The U.S. healthcare system is a behemoth -- in 2023, industrywide expenditures totaled $4.9 trillion, or $14,570 per American. UnitedHealth Group (NYSE: UNH) is at the industry's center. The

Cathie Wood's aggressive growth style of investing may have fallen flat earlier this year, but the co-founder, CEO, and ace stock picker at Ark Invest has been on a roll lately. Ark's most popular